The Nevada State Athletic Commission today voted unanimously to suspend featherweight Kurt Holobaugh nine months and fine him $750 for failing to properly disclose IV use.
Holobaugh’s (17-4) knockout win at Dana White’s Contender Series 1 over Matt Bessette (22-7) on July 11 is now overturned to a no-contest, leaving his UFC career in limbo after he reportedly earned a UFC contract in July.
The $750 fine represents 15 percent of Holobaugh’s $5,000 “show” purse for the fight.
Officials said Holobaugh didn’t notify the commission that he used an IV containing 2,000 milliliters of fluid after the event’s weigh-ins on July 10. The injection wasn’t part of a hospital procedure or surgical procedure, and he receive a therapeutic-use exemption.
Holobaugh appeared via telephone during today’s NSAC’s meeting in Las Vegas and admitted he didn’t note his use of an IV, believing he wasn’t subject to the rules of the U.S. Anti-Doping Agency (USADA), which oversees the UFC’s anti-doping program.
“I do take full responsibility,” he said.
NSAC Executive Director Bob Bennett noted that when a USADA official spoke with Holobaugh as part of his UFC contract offer, the fighter was “honest and forthright” about his omission and amended his paperwork.
Still, the NSAC felt ignorance of its rules did not excuse Holobaugh for not disclosing the IV. The NSAC follows the World Anti-Doping Agency’s (WADA’s) current guidelines for IV use, prohibiting intravenous injections of more than 50 milliliters per six hour period unless part of a hospital procedure or surgical procedure, or in the case of a TUE.
As MMAjunkie reported on Monday, WADA’s 2018 Prohibited List has changed the requirements for IV use, increasing the cutoff to 100 milliliters for IVs “and/or injections of any substance” over a 12-hour period.
The NSAC overhauled his anti-doping program in 2015 and fully implemented the changes in September 2016.view original article >>